Top Penny Stocks to Watch in March 2019

Chart of Top Penny Stocks to Watch in March 2019 - CHMA, EGY, SSKN, EYPT, RIBT
Chart of Top Penny Stocks to Watch in March 2019 – CHMA, EGY, SSKN, EYPT, RIBT – Source: TheTechnicals.com and TradingView

It’s hard to believe that March has already arrived, and equity markets continue to push higher. Needless to say, stocks have been on quite a run for the past two months from the depths of December’s lows. The benchmark S&P 500 index is up nearly 20% from the late-December bottom. And the sharp rebound and recovery has lifted nearly all areas of the market, including many penny stocks. Here, we give you the all-new March 2019 edition of our popular Top Penny Stocks to Watch. (For last month’s, see: Top Penny Stocks to Watch in February 2019.)

What are Penny Stocks?

Penny stocks are generally defined as small-to-micro-cap (low market value, or capitalization) stocks trading for under $5 per share. They’re not usually our first choice for trading and investing. But many penny stocks see spectacular gains that are hard to resist.

What are the Top Penny Stocks in March 2019?

As always, we chose our top penny stocks based on three main criteria:

  • Currently trading under $5 per share
  • Relatively high trading volume (for a penny stock)
  • Exceptional stock performance across a number of different time frames

The chart above shows the current prices of our five picks as well as their one-year returns as of the market close on Friday, 3/1/2019.

One of our picks in March also made an appearance on our February list. This is because it has continued to show superior strength against other penny stocks and the rest of the market. The continuing top stock from February is:

  • RIBT: RiceBran Technologies | Price: $3.50 (as of 3/1/2019 market close) | 1-Year Performance: +139.73% (as of 3/1/2019 market close)

Two of our other March picks have also made previous appearances on this monthly Top Penny Stocks to Watch list (prior to February). They are:

  • CHMA: Chiasma | Price: $4.37 (as of 3/1/2019 market close) | 1-Year Performance: +181.94% (as of 3/1/2019 market close)
  • SSKN: STRATA Skin Sciences | Price: $3.29 (as of 3/1/2019 market close) | 1-Year Performance: +151.15% (as of 3/1/2019 market close)

And the new picks for March are:

  • EGY: VAALCO Energy | Price: $2.27 (as of 3/1/2019 market close) | 1-Year Performance: +163.95% (as of 3/1/2019 market close)
  • EYPT: EyePoint Pharmaceuticals | Price: $2.63 (as of 3/1/2019 market close) | 1-Year Performance: +150.48% (as of 3/1/2019 market close)

What Companies are Behind These Penny Stocks?

Continuing on our list from February, RiceBran Technologies has a market cap of around $92 million, the smallest stock on our list. The company is focused on food products. Specifically, RiceBran Technologies is involved in the production, processing, stabilization and preservation of rice bran for global consumers.

A previous top performer on our list, Chiasma is a clinical-stage biopharma company that focuses on rare diseases, with around $107 million in market cap. The company is developing oral medications for the treatment of acromegaly.

Another previous top performer, STRATA Skin Sciences is a medical technology company that focuses on the therapeutic and aesthetic dermatology market. Its market cap is around $99 million.

A brand new pick for March, VAALCO Energy is a U.S.-based petroleum and natural gas exploration and production company with operations mostly off the coast of Gabon in Central Africa. Its current market cap is around $133 million.

Finally, another new pick for March is the largest stock on our list at around $243 million in market capitalization. EyePoint Pharmaceuticals is a specialty biopharmaceutical company that focuses on developing and commercializing ophthalmic products to treat serious eye disorders.


IMPORTANT: The information above should not be construed as investment advice and should not be considered as a solicitation to buy or sell securities. Past performance is not indicative of future results. Trading and investing in the financial markets involves substantial risk of loss, and may not be suitable for all investors.

Disclosure: At the time of this article’s publication, we have no position in any security or trade/investment mentioned, nor do we have any business relationship with any company whose stock may be mentioned.

You may also like...